Loading…
Procalcitonin as a marker of respiratory disorder in neonates
Background Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates. Methods A total of 155 neon...
Saved in:
Published in: | Pediatrics international 2015-04, Vol.57 (2), p.263-268 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3 |
container_end_page | 268 |
container_issue | 2 |
container_start_page | 263 |
container_title | Pediatrics international |
container_volume | 57 |
creator | Ochi, Fumihiro Higaki, Takashi Ohta, Masaaki Yamauchi, Toshifumi Tezuka, Mari Chisaka, Toshiyuki Moritani, Tomozo Tauchi, Hisamichi Ishii, Eiichi |
description | Background
Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates.
Methods
A total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non‐respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C‐reactive protein (CRP) and white blood cell (WBC) count, was analyzed.
Results
Of the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18‐trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01 ng/mL, 0.26 mg/dL, and 16 100 cells/μL, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut‐off, 3.73 ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut‐off, 0.14 mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut‐off, 15 000 cells/μL).
Conclusions
PCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC. |
doi_str_mv | 10.1111/ped.12505 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1673371758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1673371758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMoVqsH_4AseNHDtvnYbNKDB6m1lRYtqOgtZLOzsHW7qckW7b83ta0HwblkGJ55mTwInRHcIaG6C8g7hHLM99ARSRIaU4zf9kPPqIwlTkULHXs_wxhLIZND1KKcUsZScYSup84aXZmysXVZR9pHOppr9w4uskXkwC9KpxvrVlFeeuvyMA9YDbbWDfgTdFDoysPp9m2jl7vBc38UTx6H9_2bSWwSSXgsTEZTwopeQozgqQFiaE4xKziWPYxzajjwXENqjExwDkwmuSYZSTMNWY8Aa6PLTe7C2Y8l-EbNS2-gqnS4ZOkVSQVjggguA3rxB53ZpavDdWuKikAlvUBdbSjjrPcOCrVwZfj3ShGs1k5VcKp-nAb2fJu4zOZhuiN3EgPQ3QCfZQWr_5PUdHC7i4w3G6Vv4Ot3I3hXIU9w9fowVP0xTcdPbKSm7BsH444s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1672771749</pqid></control><display><type>article</type><title>Procalcitonin as a marker of respiratory disorder in neonates</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Ochi, Fumihiro ; Higaki, Takashi ; Ohta, Masaaki ; Yamauchi, Toshifumi ; Tezuka, Mari ; Chisaka, Toshiyuki ; Moritani, Tomozo ; Tauchi, Hisamichi ; Ishii, Eiichi</creator><creatorcontrib>Ochi, Fumihiro ; Higaki, Takashi ; Ohta, Masaaki ; Yamauchi, Toshifumi ; Tezuka, Mari ; Chisaka, Toshiyuki ; Moritani, Tomozo ; Tauchi, Hisamichi ; Ishii, Eiichi</creatorcontrib><description>Background
Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates.
Methods
A total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non‐respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C‐reactive protein (CRP) and white blood cell (WBC) count, was analyzed.
Results
Of the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18‐trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01 ng/mL, 0.26 mg/dL, and 16 100 cells/μL, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut‐off, 3.73 ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut‐off, 0.14 mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut‐off, 15 000 cells/μL).
Conclusions
PCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC.</description><identifier>ISSN: 1328-8067</identifier><identifier>EISSN: 1442-200X</identifier><identifier>DOI: 10.1111/ped.12505</identifier><identifier>PMID: 25223367</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Biomarkers ; Biomarkers - blood ; C-reactive protein ; C-Reactive Protein - metabolism ; Calcitonin - blood ; Female ; Humans ; Infant, Newborn ; Leukocyte Count ; Luminescent Measurements ; Male ; neonate ; Pediatrics ; procalcitonin electrochemiluminescence immunoassay ; Respiration Disorders - diagnosis ; Respiratory diseases ; ROC Curve ; Sensitivity and Specificity ; white blood cell count</subject><ispartof>Pediatrics international, 2015-04, Vol.57 (2), p.263-268</ispartof><rights>2014 Japan Pediatric Society</rights><rights>2014 Japan Pediatric Society.</rights><rights>Pediatrics International © 2015 Japan Pediatric Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3</citedby><cites>FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25223367$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ochi, Fumihiro</creatorcontrib><creatorcontrib>Higaki, Takashi</creatorcontrib><creatorcontrib>Ohta, Masaaki</creatorcontrib><creatorcontrib>Yamauchi, Toshifumi</creatorcontrib><creatorcontrib>Tezuka, Mari</creatorcontrib><creatorcontrib>Chisaka, Toshiyuki</creatorcontrib><creatorcontrib>Moritani, Tomozo</creatorcontrib><creatorcontrib>Tauchi, Hisamichi</creatorcontrib><creatorcontrib>Ishii, Eiichi</creatorcontrib><title>Procalcitonin as a marker of respiratory disorder in neonates</title><title>Pediatrics international</title><addtitle>Pediatr Int</addtitle><description>Background
Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates.
Methods
A total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non‐respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C‐reactive protein (CRP) and white blood cell (WBC) count, was analyzed.
Results
Of the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18‐trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01 ng/mL, 0.26 mg/dL, and 16 100 cells/μL, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut‐off, 3.73 ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut‐off, 0.14 mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut‐off, 15 000 cells/μL).
Conclusions
PCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC.</description><subject>Biomarkers</subject><subject>Biomarkers - blood</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - metabolism</subject><subject>Calcitonin - blood</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Leukocyte Count</subject><subject>Luminescent Measurements</subject><subject>Male</subject><subject>neonate</subject><subject>Pediatrics</subject><subject>procalcitonin electrochemiluminescence immunoassay</subject><subject>Respiration Disorders - diagnosis</subject><subject>Respiratory diseases</subject><subject>ROC Curve</subject><subject>Sensitivity and Specificity</subject><subject>white blood cell count</subject><issn>1328-8067</issn><issn>1442-200X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LAzEQhoMoVqsH_4AseNHDtvnYbNKDB6m1lRYtqOgtZLOzsHW7qckW7b83ta0HwblkGJ55mTwInRHcIaG6C8g7hHLM99ARSRIaU4zf9kPPqIwlTkULHXs_wxhLIZND1KKcUsZScYSup84aXZmysXVZR9pHOppr9w4uskXkwC9KpxvrVlFeeuvyMA9YDbbWDfgTdFDoysPp9m2jl7vBc38UTx6H9_2bSWwSSXgsTEZTwopeQozgqQFiaE4xKziWPYxzajjwXENqjExwDkwmuSYZSTMNWY8Aa6PLTe7C2Y8l-EbNS2-gqnS4ZOkVSQVjggguA3rxB53ZpavDdWuKikAlvUBdbSjjrPcOCrVwZfj3ShGs1k5VcKp-nAb2fJu4zOZhuiN3EgPQ3QCfZQWr_5PUdHC7i4w3G6Vv4Ot3I3hXIU9w9fowVP0xTcdPbKSm7BsH444s</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Ochi, Fumihiro</creator><creator>Higaki, Takashi</creator><creator>Ohta, Masaaki</creator><creator>Yamauchi, Toshifumi</creator><creator>Tezuka, Mari</creator><creator>Chisaka, Toshiyuki</creator><creator>Moritani, Tomozo</creator><creator>Tauchi, Hisamichi</creator><creator>Ishii, Eiichi</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201504</creationdate><title>Procalcitonin as a marker of respiratory disorder in neonates</title><author>Ochi, Fumihiro ; Higaki, Takashi ; Ohta, Masaaki ; Yamauchi, Toshifumi ; Tezuka, Mari ; Chisaka, Toshiyuki ; Moritani, Tomozo ; Tauchi, Hisamichi ; Ishii, Eiichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biomarkers</topic><topic>Biomarkers - blood</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - metabolism</topic><topic>Calcitonin - blood</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Leukocyte Count</topic><topic>Luminescent Measurements</topic><topic>Male</topic><topic>neonate</topic><topic>Pediatrics</topic><topic>procalcitonin electrochemiluminescence immunoassay</topic><topic>Respiration Disorders - diagnosis</topic><topic>Respiratory diseases</topic><topic>ROC Curve</topic><topic>Sensitivity and Specificity</topic><topic>white blood cell count</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ochi, Fumihiro</creatorcontrib><creatorcontrib>Higaki, Takashi</creatorcontrib><creatorcontrib>Ohta, Masaaki</creatorcontrib><creatorcontrib>Yamauchi, Toshifumi</creatorcontrib><creatorcontrib>Tezuka, Mari</creatorcontrib><creatorcontrib>Chisaka, Toshiyuki</creatorcontrib><creatorcontrib>Moritani, Tomozo</creatorcontrib><creatorcontrib>Tauchi, Hisamichi</creatorcontrib><creatorcontrib>Ishii, Eiichi</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ochi, Fumihiro</au><au>Higaki, Takashi</au><au>Ohta, Masaaki</au><au>Yamauchi, Toshifumi</au><au>Tezuka, Mari</au><au>Chisaka, Toshiyuki</au><au>Moritani, Tomozo</au><au>Tauchi, Hisamichi</au><au>Ishii, Eiichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Procalcitonin as a marker of respiratory disorder in neonates</atitle><jtitle>Pediatrics international</jtitle><addtitle>Pediatr Int</addtitle><date>2015-04</date><risdate>2015</risdate><volume>57</volume><issue>2</issue><spage>263</spage><epage>268</epage><pages>263-268</pages><issn>1328-8067</issn><eissn>1442-200X</eissn><abstract>Background
Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates.
Methods
A total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non‐respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C‐reactive protein (CRP) and white blood cell (WBC) count, was analyzed.
Results
Of the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18‐trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01 ng/mL, 0.26 mg/dL, and 16 100 cells/μL, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut‐off, 3.73 ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut‐off, 0.14 mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut‐off, 15 000 cells/μL).
Conclusions
PCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>25223367</pmid><doi>10.1111/ped.12505</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1328-8067 |
ispartof | Pediatrics international, 2015-04, Vol.57 (2), p.263-268 |
issn | 1328-8067 1442-200X |
language | eng |
recordid | cdi_proquest_miscellaneous_1673371758 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Biomarkers Biomarkers - blood C-reactive protein C-Reactive Protein - metabolism Calcitonin - blood Female Humans Infant, Newborn Leukocyte Count Luminescent Measurements Male neonate Pediatrics procalcitonin electrochemiluminescence immunoassay Respiration Disorders - diagnosis Respiratory diseases ROC Curve Sensitivity and Specificity white blood cell count |
title | Procalcitonin as a marker of respiratory disorder in neonates |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T21%3A34%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Procalcitonin%20as%20a%20marker%20of%20respiratory%20disorder%20in%20neonates&rft.jtitle=Pediatrics%20international&rft.au=Ochi,%20Fumihiro&rft.date=2015-04&rft.volume=57&rft.issue=2&rft.spage=263&rft.epage=268&rft.pages=263-268&rft.issn=1328-8067&rft.eissn=1442-200X&rft_id=info:doi/10.1111/ped.12505&rft_dat=%3Cproquest_cross%3E1673371758%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1672771749&rft_id=info:pmid/25223367&rfr_iscdi=true |